Status:
COMPLETED
Decision Aid for Patients With Generalized Anxiety Disorder: Protocol for a Randomized Controlled Trial
Lead Sponsor:
Servicio Canario de Salud
Conditions:
Generalized Anxiety Disorder
GAD
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main goal of this study is assess the effectiveness of a PtDA for patients with GAD.
Detailed Description
Background: Patients with Generalized Anxiety Disorder (GAD) have concerns and needs about their health and the health care they receive. Patient decision aids (PtDAs) are tools that assist patients i...
Eligibility Criteria
Inclusion
- Adult (≥ 18 years) with a diagnosis of GAD (ICD-10 or DSM-V codes: 300.02; F41.1), with a score ≥8 in the GAD-7 questionnaire, with ability to speak and read Spanish, and who accept to participate and sign the informed consent
Exclusion
- Patients with a primary diagnosis other than GAD, a score \<8 in the GAD-7, those with significant physical or mental disability that prevents from completion of study activities or those participating in other trials related with GAD treatment or education, will be excluded
Key Trial Info
Start Date :
May 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 13 2023
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT04364958
Start Date
May 7 2021
End Date
April 13 2023
Last Update
April 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Servicio de Evaluación del Servicio Canario de la Salud
Santa Cruz de Tenerife, Spain, 38004